ABBV-428: Clinical Trials

1 trial of ABBV-428, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow ABBV-428: new trials by email Literature Review of ABBV-428 trials Research Report on ABBV-428

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid Tumors
ABBV-428, Nivolumab - Advanced Solid Tumors Cancer
Phase 1CompletedAbbVie612016-11-182020-07-20

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)

Sponsors

AbbVie (1)

Countries

Australia (1)  ·  France (1)  ·  Taiwan (1)  ·  United States (1)

Results publications

PMID 33608377

NIH funding

2016 (1)